| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 07/09/2014 | CN103007063B 一种治疗面瘫的药物组合物及其制备方法 A treatment of facial paralysis pharmaceutical composition and preparation method |
| 07/09/2014 | CN103006988B 一种治疗多发性抽动症的中药组合物 A treatment for Tourette's herbal composition |
| 07/09/2014 | CN103006742B 一种超微玛咔全效制剂及其制备方法、剂型与应用 Supermicro Mary cracking one kind full effect and its preparation method and application forms |
| 07/09/2014 | CN102994432B 一种鼠李糖乳杆菌及其用途 One kind of Lactobacillus rhamnosus and their uses |
| 07/09/2014 | CN102988631B 一种治疗癫痫的中药制剂 A treatment for epilepsy medicine preparations |
| 07/09/2014 | CN102964403B 天麻素化合物及其药物组合物 Gastrodin compounds and pharmaceutical compositions thereof |
| 07/09/2014 | CN102949373B 一种浴足泡腾片及其制备方法 One kind of washes effervescent tablet and its preparation method |
| 07/09/2014 | CN102936250B 稠合双环mTOR抑制剂 Fused bicyclic inhibitors of mTOR |
| 07/09/2014 | CN102908521B 一种利用兰石草果治疗偏头痛的中药 A use of Portland stone strawberry treat migraine medicine |
| 07/09/2014 | CN102813746B 一种用于治疗手指麻木的中药组合物 A method for treating a finger numbing medicine composition |
| 07/09/2014 | CN102791703B 用作δ阿片类受体调节剂的吡嗪 Used as the δ-opioid receptor modulators pyrazine |
| 07/09/2014 | CN102703380B 亚全能干细胞、其制备方法及其用途 Asian totipotent stem cells, their preparation and their use |
| 07/09/2014 | CN102698149B 一种治疗慢性头痛的中药及其制备方法 A chronic headache medicine and its preparation method of treatment |
| 07/09/2014 | CN102690231B 治疗阿尔茨海默病潜在药物司马西特的合成方法 Synthesis Division 马西特 potential drugs for Alzheimer's disease treatment |
| 07/09/2014 | CN102670597B 5-(4-羟基-3-甲氧基苯亚甲基)罗丹宁在制备治疗帕金森氏病药物中的用途 5- (4-hydroxy-3-methoxybenzylidene) rhodanine in the manufacture of a medicament for the treatment of Parkinson's disease |
| 07/09/2014 | CN102630162B 4-甲基吡唑制剂 4-methyl pyrazole formulation |
| 07/09/2014 | CN102618420B 一种养生保健酒以及制作方法 One kind of health care as well as wine production methods |
| 07/09/2014 | CN102617471B 左旋美普他酚双分子衍生物和/或其盐及其制备方法和用途 L meptazinol bimolecular derivatives and / or salts thereof and its preparation and use |
| 07/09/2014 | CN102416082B 一种治疗失眠的中药提取物 A treatment for insomnia Herbal Extracts |
| 07/09/2014 | CN102361873B 作为trpa1调节剂的稠合嘧啶二酮衍生物 As fused -pyrimidinedione derivative trpa1 moderator |
| 07/09/2014 | CN102266302B 旨在避免非主观误服和非法滥服的抗张性片剂 Designed to avoid the reach of non-subjective and illegal Lanfu tensile tablets |
| 07/09/2014 | CN102216304B 二氢四氮杂苯并薁的烷基环己基醚 Dihydro-tetraazabenzo azulene alkyl cyclohexyl ether |
| 07/09/2014 | CN102203077B 用于治疗疼痛的(吡咯烷-2-基)苯基衍生物 For the treatment of pain (pyrrolidin-2-yl) phenyl derivative |
| 07/09/2014 | CN102014969B 用于包括灌注成像在内的应用的造影剂 Is used to include perfusion imaging applications including contrast agent |
| 07/09/2014 | CN101878193B 双环γ-氨基酸衍生物 Γ- bicyclic amino acid derivatives |
| 07/09/2014 | CN101829108B 一种二萜内酯类化合物的用途 Uses a diterpene lactone compound |
| 07/09/2014 | CN101627974B 一日服用一次的羟考酮制剂 Taken once a day formulation of oxycodone |
| 07/09/2014 | CN101541193B 包含含有三环二萜及其衍生物的混合物的鼠尾草提取物的膳食和药物组合物及其用途 Comprises a mixture comprising the tricyclic diterpenes and their derivatives of the sage extract dietary and pharmaceutical compositions and uses thereof |
| 07/09/2014 | CN101531653B 3-(4-氨基-1-氧代-1,3-二氢异吲哚-2-基)哌啶-2,6-二酮及其衍生物的盐或盐的多晶型物及其制备和应用 3- (4-amino-1-oxo-1,3-dihydro-isoindol-2-yl) piperidine-2,6-dione and its derivatives of the salt or salts and polymorphs Preparation and Application |
| 07/09/2014 | CN101355953B 麻醉苏醒促进剂 Anesthesia accelerator |
| 07/08/2014 | US8772511 Azabicyclic carbamates and their use as alpha-7 nicotinic acetylcholine receptor agonists |
| 07/08/2014 | US8772479 Oligomer-containing substituted aromatic triazine compounds |
| 07/08/2014 | US8772313 Benzenesulfonyl or sulfonamide compounds suitable for treating disorders that respond to the modulation of the serotonin 5-HT6 receptor |
| 07/08/2014 | US8772307 Substituted spiro compounds and their use for producing pain-relief medicaments |
| 07/08/2014 | US8772275 Mediators of hedgehog signaling pathways, compositions and uses related thereto |
| 07/08/2014 | US8771757 Method for the preparation of a silicic acid comprising extrudate, said extrudate, its use and a pharmaceutical composition comprising the said extrudate |
| 07/08/2014 | US8771755 Preparation and compositions of highly bioavailable zerovalent sulfur and uses thereof |
| 07/08/2014 | CA2763960C Bicyclic and tricyclic compounds as kat ii inhibitors |
| 07/08/2014 | CA2652220C Adhesive preparation comprising methyl salicylate for percutaneous absorption |
| 07/08/2014 | CA2643722C Use of the engrailed homeodomain protein as an anxiolytic |
| 07/08/2014 | CA2635850C Heterocyclic janus kinase 3 inhibitors |
| 07/08/2014 | CA2624504C Benzimidazolone compounds which have activity at m1 receptor and their uses in medicine |
| 07/08/2014 | CA2624141C Quinazoline derivative and pharmaceutical |
| 07/08/2014 | CA2617107C Olanzapine analogs and methods of use thereof |
| 07/08/2014 | CA2604052C Methods and compositions for the treatment of cns-related conditions |
| 07/08/2014 | CA2596736C Tricyclic cytoprotective compounds |
| 07/08/2014 | CA2595800C Specific binding members for ngf |
| 07/08/2014 | CA2568213C Composition and method for the treatment of tauopathies |
| 07/08/2014 | CA2544050C Use of plant parts of prickly pear (opuntia) and/or extracts therefrom for the treatment of depressions |
| 07/08/2014 | CA2480712C Chondrocyte therapeutic delivery system |
| 07/08/2014 | CA2469370C Adipose-derived cell processing unit |
| 07/08/2014 | CA2447593C Ex-vivo priming for generating cytotoxic t lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease |
| 07/08/2014 | CA2444959C Progenitor cell populations, expansion thereof, and growth of non-hematopoietic cell types and tissues therefrom |
| 07/08/2014 | CA2417568C Growth differentiation factor receptors, agonists and antagonists thereof, and methods of using same |
| 07/08/2014 | CA2350395C Nucleotide and protein sequences of nogo genes and methods based thereon |
| 07/08/2014 | CA1341639C Recombinant fibroblast growth factors |
| 07/03/2014 | WO2014106238A1 Heterocyclic compounds and methods of use thereof |
| 07/03/2014 | WO2014106050A1 Compositions comprising lithium |
| 07/03/2014 | WO2014105870A1 Enhancing health in mammals using telomerase reverse transcriptase gene therapy |
| 07/03/2014 | WO2014105666A1 Heterobicyclo-substituted-[1,2,4]triazolo[1,5-c]quinazolin-5-amine compounds with a2a antagonist properties |
| 07/03/2014 | WO2014105620A1 Use of pregn-4-en-20-yn-3-one for the treatment of depressive disorders |
| 07/03/2014 | WO2014105576A1 Eicosapentaenoic acid (epa) formulations |
| 07/03/2014 | WO2014104757A1 2,3-dihydro-isoindole-1-on derivative as btk kinase suppressant, and pharmaceutical composition including same |
| 07/03/2014 | WO2014104414A1 Salts and crystal forms |
| 07/03/2014 | WO2014104372A1 Halogen-substituted heterocyclic compound |
| 07/03/2014 | WO2014104272A1 Cinnamic acid amide derivative |
| 07/03/2014 | WO2014104220A1 Packaging |
| 07/03/2014 | WO2014104171A1 Skin-exterior anti-ageing composition and production method therefor |
| 07/03/2014 | WO2014103801A1 Oct3 activity inhibitor containing imidazopyridine derivative as active component, and oct3 detection agent |
| 07/03/2014 | WO2014103481A1 Cyclic peptide and pharmaceutical product containing same |
| 07/03/2014 | WO2014103475A1 Skin-exterior anti-ageing composition and production method therefor |
| 07/03/2014 | WO2014102780A1 ANTI-NEUROINFLAMMATORY, ANTIOXIDATIVE AND PROTECTIVE EFFECTS OF Pi INFUSION |
| 07/03/2014 | WO2014102589A1 Quinazolin-4(3h)-one-type piperidine compounds and uses thereof |
| 07/03/2014 | WO2014102417A1 USE OF BICYCLIC DERIVATIVES OF 1-DEOXYGALACTONOJIRIMYCIN IN THE PRODUCTION OF A MEDICAMENT FOR THE TREATMENT OF DISEASES ASSOCIATED WITH MUTANT HUMAN LYSOSOMAL GALACTOSIDASE ß-ENZYMES |
| 07/03/2014 | WO2014102377A1 Azaindole derivatives as multi kinase inhibitors |
| 07/03/2014 | WO2014102339A1 Sulphate salts of n-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1h-benzo[d]imidazol-2-amine, preparation thereof and use of the same |
| 07/03/2014 | WO2014102233A1 Comt inhibitors |
| 07/03/2014 | WO2014102090A1 4-hydroxy-2-methyl-5-(propan-2-ylidene)cyclohex-3-enecarbaldehyde for the prevention and treatment of a cognitive, neurodegenerative or neuronal disease |
| 07/03/2014 | WO2014101373A1 Heterobicyclo-substituted-[1,2,4]triazolo[1,5-c]quinazolin-5-amine compounds for treatment of central nervous system disorder |
| 07/03/2014 | WO2014101295A2 Isoxazole derivative that inhibits activity of janus kinases (jaks) |
| 07/03/2014 | WO2014101120A1 Heterobicyclo-substituted-7-methoxy-[1,2,4]triazolo[1,5-c]quinazolin-5-amine compounds with a2a antagonist properties |
| 07/03/2014 | WO2014101113A1 Piperazine-substituted 7-methoxy-[1,2,4]triazolo[1,5-c]quinazolin-5-amine compounds with a2a antagonist properties |
| 07/03/2014 | WO2014100934A1 Glycosidase inhibitors and uses thereof |
| 07/03/2014 | US20140187772 Pyrazole compounds useful as protein kinase inhibitors |
| 07/03/2014 | US20140187747 Discordant Helix Stabilization For Prevention of Amyloid Formation |
| 07/03/2014 | US20140187597 Pharmaceutical compositions for the treatment of movement disorders |
| 07/03/2014 | US20140187505 Cardiac Glycosides to Treat Cystic Fibrosis and Other IL-8 Dependent Disorders |
| 07/03/2014 | US20140187485 Novel receptor nucleic acids and polypeptides |
| 07/03/2014 | US20140186400 Methods and compositions for treating autoimmune diseases |
| 07/03/2014 | US20140186368 METHODS OF ADMINISTERING ANTI-TNFalpha ANTIBODIES |
| 07/02/2014 | EP2749571A2 Methods of treating pain and inflammation in neuronal tissue using IL-31RA and OSMRb antagonists |
| 07/02/2014 | EP2749556A1 An improved process for the preparation of pure cyamemazine and salts thereof |
| 07/02/2014 | EP2749554A2 2,5-disubstituted arylsulfonamide CCR3 antagonists |
| 07/02/2014 | EP2749281A1 Prophylactic/therapeutic agent for cardiovascular complications of diabetes |
| 07/02/2014 | EP2748614A2 Method of screening for chaperonin modulator |
| 07/02/2014 | EP2748198A2 Method of treating multiple sclerosis by intrathecal depletion of b cells and biomarkers to select patients with progressive multiple sclerosis |
| 07/02/2014 | EP2748170A1 1,4-diazabicyclo[3.2.2]nonanes as neuronal nicotinic acetylcholine receptor ligands |
| 07/02/2014 | EP2748162A1 2 -amino-4 - (pyridin- 2 -yl) - 5, 6 -dihydro-4h- 1, 3 -oxazine derivatives and their use as bace-1 and/or bace - 2 inhibitors |
| 07/02/2014 | EP2748149A1 Pyridazinone compounds and their use as daao inhibitors |
| 07/02/2014 | EP2747770A1 Treatments involving eslicarbazepine acetate or eslicarbazepine |